Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1

NCT02724358 is registered in ClinicalTrials.gov with Eastern Hepatobiliary Surgery Hospital as lead sponsor.

NCT NCT02724358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02724358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
Lead sponsor
Eastern Hepatobiliary Surgery Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2012
Completion date
December 31, 2015
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, notch1, rg3, tace